SCHEMBL3979527

SCHEMBL3979527

NNC(=O)c1occc1-c1ccc(OCC(=O)c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.51
NPC1 O15118 3/20 0.51
MAPT P10636 7/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
RAB9A P51151 3/20 0.49
LMNA P02545 3/20 0.48
MEN1 O00255 6/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
LTA4H P09960 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3983418 0.84 PORCN (0.50) KMT2ANPC1MAPTSMN1; SMN2RAB9A
SCHEMBL3977386 0.83 MAPT (0.52) NPC1MAPTSMN1; SMN2RAB9AALDH1A1
SCHEMBL3976519 0.82 NPC1 (0.44) KMT2ANPC1MAPTSMN1; SMN2RAB9A
SCHEMBL4285451 0.80 MAPT (0.43) KMT2AMAPTMEN1L3MBTL1ALDH1A1
SCHEMBL3982394 0.74 ALDH1A1 (0.37) KMT2ALMNAMEN1ALDH1A1NPSR1
SCHEMBL1311321 0.74 MAPT (0.79) KMT2ANPC1MAPTSMN1; SMN2RAB9A
SCHEMBL9786970 0.74 MAPT (0.74) KMT2ANPC1MAPTSMN1; SMN2RAB9A
SCHEMBL12951705 0.74 ALDH1A1 (0.61) NPC1MAPTRAB9ALMNATDP1
SCHEMBL3982443 0.74 NPSR1 (0.43) KMT2AMAPTLMNAMEN1L3MBTL1
SCHEMBL141046 0.73 MAPT (0.37) KMT2AMAPTSMN1; SMN2MEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 KMT2A 3459/4885NPC1 1584/4885MAPT 4833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.